These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7808178)

  • 1. [Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?].
    Wilhelmson B
    Lakartidningen; 1994 Dec; 91(49):4635-6. PubMed ID: 7808178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is oxymetazoline really safe for middle ear use.
    Seidman MD
    Laryngoscope; 2005 Jul; 115(7):1321-3; author reply 1323. PubMed ID: 15995530
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS reactions to nose drops in small children.
    Söderman P; Sahlberg D; Wiholm BE
    Lancet; 1984 Mar; 1(8376):573. PubMed ID: 6142294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nose drops--therapeutic effects and applications].
    Reiss M; Reiss G
    Praxis (Bern 1994); 2001 Jun; 90(25-26):1145-7. PubMed ID: 11469055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Xylometazoline (Otrivin) in acute rhinitis. A comparative study between pipette- and metered-dose aerosol applications].
    Myklebust G; Sandvik L; Frostad AB
    Tidsskr Nor Laegeforen; 1984 Oct; 104(29):2024-5. PubMed ID: 6150564
    [No Abstract]   [Full Text] [Related]  

  • 14. Nose drops induce vasomotion in the microcirculation of the sinus mucosa of the rabbit.
    Bende M; Arfors KE; Intaglietta M
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):110-3. PubMed ID: 7680443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overuse of nasal adrenergic agents--time for a warning, again!].
    Holmström M
    Lakartidningen; 2007 Feb 21-27; 104(8):612. PubMed ID: 17396466
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period.
    Petruson B
    Rhinology; 1981 Sep; 19(3):167-72. PubMed ID: 6171024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
    Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of anticholinergics to treat bradycardia caused by alpha1-adrenergic agonist overdose is not safe.
    Sprung J; Alhaddad ST
    J Clin Anesth; 1996 Aug; 8(5):426-7. PubMed ID: 8832455
    [No Abstract]   [Full Text] [Related]  

  • 19. Paranoid psychosis induced by oxymetazoline nasal spray.
    Ticoll B; Shugar G
    CMAJ; 1994 Feb; 150(3):375-6. PubMed ID: 8293377
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status Migrainosus.
    Darsey M; Kyros T; Wang V; Rizzoli PB
    Headache; 2020 Feb; 60(2):471-472. PubMed ID: 31919839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.